EVALUATION OF IN VIVO ANTI-DIABETIC ACTIVITY OF ROOT OF CRATAEVA MAGNA LOUR., ON STREPTOZOTOCIN-INDUCED DIABETIC RATS
Keywords:Crataeva magna, Root, In vivo, Acute toxicity, Anti-diabetic, Biochemical parameters
Objective: The purpose of the study is to evaluate the anti-diabetic effect of the ethanolic extract of root of Crataeva magna Lour., on streptozotocin-induced diabetic rats.
Methods: Streptozotocin (45 mg/kg) was used to induce the diabetes mellitus in rats. Afterward, the diabetic rats will be divided into four groups Group I rats served as diabetic control rats, Group II rats were induced diabetes and treated with standard drug through oral intragastric tube, Group III and Group IV were treated with ethanolic extract (200 and 400 mg/kg). Glibenclamide as reference was to evaluate the effect of the extract.
Results: The administration of extract decreased the fasting blood glucose and body weight as well as increased level of total cholesterol and triglycerides which and decreased and HDL level. SGPT and SGOT level were significantly reduced in treatment group. Blood urea and creatinine were a significant difference in blood urea and creatinine.
Conclusion: The extract of C.magna Lour. exhibited significant anti-diabetic activity evident from blood glucose level, body weight, serum cholesterol profile, SGOT, SGPT, serum creatinine, and serum urea level.
Satoskar RS, Rege N, Bhandarkar SD. Pharmacology and Pharmacotherapeutics. 24th ed. London: Elsevier; 2015. p. 885.
Craig CR, Stitzel RE. Modern Pharmacology with Clinical Applications. 6th ed. New Delhi: Wolters Kluwer India Pvt. Ltd.; 2012. p. 767.
Bennett PN, Brown MJ, Shrma P. Clinical Pharmacology. 11th ed. London: Elsevier; 2012. p. 572.
Behera S, Behera B, Barik DP, Naik SK. Phytochemical analysis of the leaf, flower, and bark of A medicinal plant, Crataeva magna (Lour.) DC. Asian J Pharm Clin Res 2016;9:177-8.
Sangeetha MS, Priyanga S, Hemmalakshmi S, Devaki K. In vivo antidiabetic potential of Cyclea peltata in streptozotocin-induced-diabetic rats. Asian J Pharm Clin Res 2015;8:103-8.
Dace JV. Biochemical Parameters: Practical Hematology. 6th ed. London: Churchill Livingstone; 1985. p. 28.
Burtis CA, Ashwood ER. Tietz Biochemical Parameters: Textbook of Clinical Chemistry. 2nd ed. Philadelphia, PA: Saunders WB Company; 1994. p. 1016-8.
National Committee for Clinical Laboratory Standards. User evaluation Precision Performance of clinical chemistry Devices. NCCLS. New York: National Committee for Clinical Laboratory Standards Publication; 1984. Available from: http://www.thermo.com/eThermo/CMA/PDF/s/Product/ productPDF50918. [Last accessed on 2020 Dec 13].
Chernecky CC, Berger VJ. Laboratory Tests and Diagnostic Procedure. 4th ed. Philadelphia, PA: Saunders; 2004.
Brandstrup N, Kirk JE, Bruni C. The hexokinase and phosphoglucoisomerase activities of aortic and pulmonary artery tissue in individuals of various ages. J Gerontol 1957;12:166-71. doi: 10.1093/ geronj/12.2.166, PMID 13416554
Anderson WB, Nordlie RC. Glucose dehydrogenase activity of yeast of glucose-6-phosphate dehydrogenase. I. Selective stimulation bicarbonate, phosphate, by and sulphate. J Biol Chem 1968;7:1479-85.
King J. A routine method for estimation of lactate dehydrogenase activity. J Med Lab Technol 1959;16:256-72.
How to Cite
Copyright (c) 2022 A.MANOJ KUMAR, DR
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.